Probiotics in Aging Skin

  • Benedetta Cinque
  • Paola Palumbo
  • Cristina La Torre
  • Esterina Melchiorre
  • Daniele Corridoni
  • Gianfranca Miconi
  • Luisa Di Marzio
  • Maria Grazia Cifone
  • Maurizio Giuliani

Abstract

Health benefits of probiotics have been established by several studies in animals and humans and the scientific literature shows that the clinical uses of probiotics are broad and are open to continuing evaluation. The most common microorganisms used as probiotics are strains of lactic acid bacteria (LAB), which are gram-positive, nonsporing, catalase-negative organisms that are devoid of cytochromes and of nonaerobic habit, but are aerotolerant, acid-tolerant, and strictly fermentative; lactic acid is the major end product of sugar fermentation. Particular attention is paid to specific species of lactic acid bacteria (LAB), including Lactobacilli and Bifidobacteria, that are part of the intestinal microbiota. Most probiotics are included in foods or dietary supplements and are aimed at functioning in the intestine. However, even if gastrointestinal tract has been the primary target, it is becoming evident that other conditions not initially associated with the gut microbiota might also be affected by probiotics.

References

  1. 1.
    Fioramonti J, et al. Probiotics: what are they? What are their effects on gut physiology? Best Pract Res Clin Gastroenterol. 2003;17(5):711–724.PubMedGoogle Scholar
  2. 2.
    Reid G. How science will help shape future clinical applications of probiotics. Clin Infect Dis. 2008;46(Suppl. 2):S62–S66.PubMedGoogle Scholar
  3. 3.
    Silva M, et al. Antimicrobial substance from a human Lactobacillus strain. Antimicrob Agents Chemother. 1987;31:1231–1233.PubMedGoogle Scholar
  4. 4.
    Heczko PB, et al. Critical evaluation of probiotic activity of lactic acid bacteria and their effects. J Physiol Pharmacol. 2006;57(Suppl 9):S5–S12.Google Scholar
  5. 5.
    Gionchetti P, et al. Antibiotics and probiotics in treatment of inflammatory bowel disease. World J Gastroenterol. 2006;12:3306–3313.PubMedGoogle Scholar
  6. 6.
    Farnworth ER. The evidence to support health claims for probiotics. J Nutr. 2008;138(6):1250S–1254S.PubMedGoogle Scholar
  7. 7.
    Sleator RD, et al. New frontiers in probiotic research. Lett Appl Microbiol. 2008;46(2):143–147.PubMedGoogle Scholar
  8. 8.
    Di Marzio L, et al. Apoptotic effects of selected strains of lactic acid bacteria on a human T leukemia cell line are associated with bacterial arginine deiminase and/or sphingomyelinase activities. Nutr Cancer. 2001;40(2):185–196.PubMedGoogle Scholar
  9. 9.
    de Moreno de LeBlanc A, et al. The application of probiotics in cancer. Br J Nutr. 2007;98(Suppl 1):S105–S110.PubMedGoogle Scholar
  10. 10.
    Goldin BR. Clinical indications for probiotics: an overview. Clin Infect Dis. 2008;46(Suppl 2):S96–S100.PubMedGoogle Scholar
  11. 11.
    Macpherson AJ, et al. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science. 2004;303:1662–1665.PubMedGoogle Scholar
  12. 12.
    Fisher GJ, et al. Mechanisms of photoaging and chronological skin aging. Arch Dermatol. 2002;138(11):1462–1470.PubMedGoogle Scholar
  13. 13.
    Bojar RA, et al. Review: the human cutaneous microflora and factors controlling colonisation. World J Microbiol Biotechnol. 2002;18(9):889–903.Google Scholar
  14. 14.
    Cogen AL, et al. Skin microbiota: a source of disease or defence? Br  J Dermatol. 2008;158(3):442–455.Google Scholar
  15. 15.
    Ouwehand AC, et al. Probiotics for the skin: a new area of potential application? Lett. Appl Microbiol. 2003;36(5):327–331.Google Scholar
  16. 16.
    Tannock GW. Normal Microflora. An Introduction to Microbes Inhabiting the Human Body. London: Chapman & Hall, 1995.Google Scholar
  17. 17.
    Suomalainen R, et al. Propionic acid bacteria as protective cultures in fermented milks and breads. Lait. 1999;79:165–174.Google Scholar
  18. 18.
    Fluhr JW, et al. Generation of free fatty acids from phospholipids regulates stratum corneum acidification and integrity. J Invest Dermatol. 2001;117:44–51.PubMedGoogle Scholar
  19. 19.
    Fluhr JW, et al. Stratum corneum acidification in neonatal skin: secretory phospholipase A2 and the sodium/hydrogen antiporter-1 acidify neonatal rat stratum corneum. J Invest Dermatol. 2004;122:320–329.PubMedGoogle Scholar
  20. 20.
    Lambers H, et al. Natural skin surface pH is on average below 5, which is beneficial for its resident flora. Int J Cosmet Sci. 2006;28(5):359–370.PubMedGoogle Scholar
  21. 21.
    Mauro T. SC pH: measurement, origins, and functions. In: Elias P, Feingold K (eds) Skin Barrier. New York: Taylor & Francis, 2006, pp. 223–229.Google Scholar
  22. 22.
    Fluhr JW, et al. Functional consequences of a neutral pH in neonatal rat stratum corneum. J Invest Dermatol. 2004;123:140–151.PubMedGoogle Scholar
  23. 23.
    Hachem JP, et al. pH directly regulates epidermal permeability barrier homeostasis, and stratum corneum integrity/cohesion. J Invest Dermatol. 2003;121:345–353.PubMedGoogle Scholar
  24. 24.
    Hachem JP, et al. Sustained serine proteases activity by prolonged increase in pH leads to degradation of lipid processing enzymes and profound alterations of barrier function and stratum corneum integrity. J Invest Dermatol. 2005;125:510–520.PubMedGoogle Scholar
  25. 25.
    Waller JM, et al. Age and skin structure and function, a quantitative approach (I): blood flow, pH, thickness, and ultrasound echogenicity. Skin Res Technol. 2005;11(4):221–235.PubMedGoogle Scholar
  26. 26.
    Choi EH, et al. Stratum corneum acidification is impaired in moderately aged human and murine skin. J Invest Dermatol. 2007;127(12):2847–2856.PubMedGoogle Scholar
  27. 27.
    Yadav H, et al. Production of free fatty acids and conjugated linoleic acid in probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei during fermentation and storage. Intern. Dairy J. 2007;17(8):1006–1010.Google Scholar
  28. 28.
    Holleran WM, et al. Epidermal sphingolipids: metabolism, function, and roles in skin disorders. FEBS Lett. 2006;580(23):5456–5466.PubMedGoogle Scholar
  29. 29.
    Di Marzio L, et al. Effect of the lactic acid bacterium Streptococcus thermophilus on ceramide levels in human keratinocytes in vitro and stratum corneum in vivo. J Invest Dermatol. 1999;113(1):98–106.PubMedGoogle Scholar
  30. 30.
    Di Marzio L, et al. Effect of the lactic acid bacterium Streptococcus thermophilus on stratum corneum ceramide levels and signs and symptoms of atopic dermatitis patients. Exp Dermatol. 2003;12(5):615–620.PubMedGoogle Scholar
  31. 31.
    Di Marzio L, et al. Increase of skin-ceramide levels in aged subjects following a short-term topical application of bacterial sphingomyelinase from Streptococcus thermophilus. Int J Immunopathol Pharmacol. 2008;21(1):137–143.PubMedGoogle Scholar
  32. 32.
    Denda M, et al. Age- and sex-dependent change in stratum corneum sphingolipids. Arch Dermatol Res. 1993;285(7):415–417.PubMedGoogle Scholar
  33. 33.
    Motta S, et al. Abnormality of water barrier function in psoriasis. Role of ceramide fractions. Arch Dermatol. 1994;130(4):452–456.PubMedGoogle Scholar
  34. 34.
    Jensen JM, et al. Acid and neutral sphingomyelinase, ceramide synthase, and acid ceramidase activities in cutaneous aging. Exp Dermatol. 2005;14(8):609–618.PubMedGoogle Scholar
  35. 35.
    Kohen R, et al. Skin low molecular weight antioxidants and their role in aging and in oxidative stress. Toxicology. 2000;148(2–3):149–157.PubMedGoogle Scholar
  36. 36.
    Hensley K, et al. Reactive oxygen species and protein oxidation in aging: a look back, a look ahead. Arch Biochem Biophys. 2002;397(2):377–383.PubMedGoogle Scholar
  37. 37.
    Tzaphlidou M. The role of collagen and elastin in aged skin: an image processing approach. Micron. 2004;35(3):73–177.Google Scholar
  38. 38.
    Dalle Carbonare M, et al. Skin photosensitizing agents and the role of reactive oxygen species in photoaging. J Photochem Photobiol. 1992;14(1–2):105–124.Google Scholar
  39. 39.
    Helfrich YR, et al. Overview of skin aging and photoaging. Dermatol Nurs. 2008;20(3):177–183.PubMedGoogle Scholar
  40. 40.
    Kodali VP, et al. Antioxidant and free radical scavenging activities of an exopolysaccharide from a probiotic bacterium. Biotechnol J. 2008;3(2):245–251.PubMedGoogle Scholar
  41. 41.
    Cerning J. Exocellular polysaccharides produced by lactic acid bacteria. FEMS Microbiol Rev. 1990;7(1–2):113–130.PubMedGoogle Scholar
  42. 42.
    Welman AD, et al. Exopolysaccharides from lactic acid bacteria: perspectives and challenges. Trends Biotechnol. 2003;21(6):269–274.PubMedGoogle Scholar
  43. 43.
    Kishk YFM, et al. Free-radical scavenging and antioxidative activities of some polysaccharides in emulsions. LWT Food Sci Technol. 2007;40(2):270–277.Google Scholar
  44. 44.
    Bruno-Bárcena JM, et al. Expression of a heterologous manganese superoxide dismutase gene in intestinal lactobacilli provides protection against hydrogen peroxide toxicity. Appl Environ Microbiol. 2004;70(8):4702–4710.PubMedGoogle Scholar
  45. 45.
    Kang S, et al. Photoaging and topical tretinoin: therapy, pathogenesis, and prevention. Arch Dermatol. 1997;133(10):1280–1284.PubMedGoogle Scholar
  46. 46.
    Massagué J. TGF-β signal transduction. Annu Rev Biochem. 1998;67:753–791.PubMedGoogle Scholar
  47. 47.
    Chung JH, et al. Decreased extracellular-signal-regulated kinase and increased stress-activated MAP kinase activities in aged human skin in vivo. J Invest Dermatol. 2000;115(2):177–182.PubMedGoogle Scholar
  48. 48.
    Fisher GJ, et al. Mechanisms of photoaging and chronological skin aging. Arch Dermatol. 2002;138(11):1462–1470.PubMedGoogle Scholar
  49. 49.
    Varani J, et al. Vitamin A antagonizes decreased cell growth and elevated collagen-degrading matrix metalloproteinases and stimulates collagen accumulation in naturally aged human skin. J Invest Dermatol. 2000;114(3):480–486.PubMedGoogle Scholar
  50. 50.
    Jenkins G. Molecular mechanisms of skin ageing. Mech Ageing Dev. 2002;123(7):801–810.PubMedGoogle Scholar
  51. 51.
    Ulisse S, et al. Expression of cytokines, inducible nitric oxide synthase, and matrix metalloproteinases in pouchitis: effects of probiotic treatment. Am J Gastroenterol. 2001;96(9):2691–2699.PubMedGoogle Scholar
  52. 52.
    Riccia DN, et al. Anti-inflammatory effects of Lactobacillus brevis (CD2) on periodontal disease. Oral Dis. 2007;13(4):376–385.PubMedGoogle Scholar
  53. 53.
    Moorthy G, et al. Protective role of lactobacilli in Shigella dysenteriae 1-induced diarrhea in rats. Nutrition. 2007;23(5):424–433.PubMedGoogle Scholar
  54. 54.
    Dorshkind K. The ageing immune system: is it ever too old to become young again? Nat Rev Immunol. 2009;9(1):57–62.Google Scholar
  55. 55.
    Victor VM, et al. N-acetylcysteine improves in vitro the function of macrophages from mice with endotoxininduced oxidative stress. Free Radic Res. 2002;36:33–45.PubMedGoogle Scholar
  56. 56.
    Dewberry C, et al. Skin cancer in elderly patients. Dermatol Clin North Am. 2004;22:93–96.Google Scholar
  57. 57.
    Nova E, et al. Immunomodulatory effects of probiotics in different stages of life. Br J Nutr. 2007;98(Suppl 1):S90–S95.PubMedGoogle Scholar
  58. 58.
    Chiang BL, et al. Enhancing immunity by dietary consumption of a probiotic lactic acid bacterium (Bifidobacterium lactis HN019): optimization and definition of cellular immune responses. Eur J Clin Nutr. 2000;54:849–855.PubMedGoogle Scholar
  59. 59.
    Gill HS, et al. Optimizing immunity and gut function in the elderly. J Nutr Health Aging. 2001;5:80–91.PubMedGoogle Scholar
  60. 60.
    Caramia G, et al. Probiotics and the skin. Clin Dermatol. 2008;26(1):4–11.PubMedGoogle Scholar
  61. 61.
    Isolauri E. Probiotics in human disease. Am J Clin Nutr. 2001;73:S1142–S1146.Google Scholar
  62. 62.
    Cals-Grierson MM, et al. Nitric oxide function in the skin. Nitric Oxide. 2004;10(4):179–193.PubMedGoogle Scholar
  63. 63.
    Ouwehand AC, et al. Bifidobacterium microbiota and parameters of immune function in elderly subjects. FEMS Immunol Med Microbiol. 2008;53(1):18–25.PubMedGoogle Scholar
  64. 64.
    Guéniche A, et al. Supplementation with oral probiotic bacteria maintains cutaneous immune homeostasis after UV exposure. Eur J Dermatol. 2006;16:511–517.PubMedGoogle Scholar
  65. 65.
    Peguet-Navarro J, et al. Supplementation with oral probiotic bacteria protects human cutaneous immune homeostasis after UV exposure-double blind, randomized, placebo controlled clinical trial. Eur J Dermatol. 2008;18:504–511.PubMedGoogle Scholar
  66. 66.
    Canche-Pool EB, et al. Probiotics and autoimmunity: an evolutionary perspective. Med Hypotheses. 2008;70:657–660.PubMedGoogle Scholar
  67. 67.
    Hsu CJ, et al. Emerging treatment of atopic dermatitis. Clin Rev Allergy Immunol. 2007;33:199–203.PubMedGoogle Scholar
  68. 68.
    Railan D, et al. Ablative treatment of photoaging. Dermatol Ther. 2005;18:227–241.PubMedGoogle Scholar
  69. 69.
    Gorbach SL. Probiotics in the Third Millennium. Digest Liver Dis. 2002;34(Suppl 2):2–7.Google Scholar
  70. 70.
    Fan YF, et al. Preparation of insulin nanoparticles and their encapsulation with biodegradable polyelectrolytes via the layer-by-layer adsorption. Int J Pharm. 2006;324:158–167.PubMedGoogle Scholar
  71. 71.
    Hooper LV, et al. A molecular sensor that allows a gut commensal to control its nutrient foundation in a competitive ecosystem. Proc Natl Acad Sci USA 1999;17(96):9833–9838.Google Scholar
  72. 72.
    Sheehan VM, et al. Heterologous expression of BetL, a betaine uptake system, enhances the stress tolerance of Lactobacillus salivarius UCC118. Appl Environ Microbiology. 2006;72(3):2170–2177.Google Scholar
  73. 73.
    Sheehan VM, et al. Improving gastric transit, gastrointestinal persistence and therapeutic efficacy of the probiotic strain Bifidobacterium breve UCC2003. Microbiol. 2007;153(10):3563–3571.Google Scholar
  74. 74.
    Saunders S, et al. Effect of Lactobacillus challenge on Gardnerella vaginalis biofilms. Colloids Surf B Biointerfaces. 2007;55(2):138–142.PubMedGoogle Scholar
  75. 75.
    Thurnheer T, et al. Multiplex FISH analysis of a six-species bacterial biofilm. J Microbiol Methods. 2004;56:37–47.PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2010

Authors and Affiliations

  • Benedetta Cinque
    • 1
  • Paola Palumbo
    • 1
  • Cristina La Torre
    • 1
  • Esterina Melchiorre
    • 1
  • Daniele Corridoni
    • 1
  • Gianfranca Miconi
    • 1
  • Luisa Di Marzio
    • 1
  • Maria Grazia Cifone
    • 1
  • Maurizio Giuliani
    • 1
  1. 1.Department of Health’s SciencesUniversity of L’AquilaCoppitoItaly

Personalised recommendations